The use of HPLC method for analysis of prazosin hydrochloride suitable for a chemical-toxicological investigation

Authors

DOI:

https://doi.org/10.15587/2519-4852.2017.109053

Keywords:

prazosin hydrochloride, identification, quantitative determination, HPLC (high performance liquid chromatography)

Abstract

Aim of research is the identification and quantification of prazosin hydrochloride according to the unified HPLC method that based on application:

reverse-phase chromatography, linear gradient and multichannel UV-detecting substances. The method allows obtaining reliable results of studies of drugs and mixtures in biological objects.

Materials and methods. HPLC chromatography was performed on microcolumn liquid chromatograph "Milichrome A-02" ("EcoNova" Novosibirsk, Russia) in reverse-phase variant. In this work the reagents of the qualification "for HPLC" and "PFA" were used. Prazosin hydrochloride was isolated from tablets Prazosin-Ratiofarm (50 pcs.) of 1 mg (Merkel GmbH & Co., Germany). Purity of the substance was checked by TLC and UV spectroscopy and the quality complies with the requirements of the SPhU.

Results of the research. During identification, absolute retention time (15.99–16.12 min) and retention volume (1598.5–1611.5 μl) of prazosin hydrochloride spectral relations, detection limit of medicine in the sample (8.0 µg / ml or 32.0 ng of sample), values of coefficients peak symmetry (0.96–1.04) and coefficients of capacity ratio (9.44–9.96) were determined.

The regression coefficients of calibration curve were calculated by the method of least squares with the equation of the line S = 0.00134 С. Correlation coefficient equaled 0.9993. Validation characteristics of HPLC-method for determination of prazosin hydrochloride: linearity range (10.0–200.0 µg / ml), limit of quantitative determination (10.0 µg / ml or 40 ng of sample), correctness and accuracy, which based on the quantitative determination results of the preparation by HPLC method in the model solutions (RSD=67.9 %) were calculated. It is established that the relative uncertainty of the average result was not exceeded +1.89 % when using the proposed method of HPLC analysis of prazosin hydrochloride in model solutions.

Conclusion. Identification and quantification of prazosin hydrochloride was carried out using a unified HPLC method suitable for a chemical toxicological study

Author Biographies

Оlena Mamina, National Pharmaceutical University Pushkinska str., 53, Kharkiv, Ukraine, 61002

Doctor of Pharmaceutical Sciences, Professor

Department of Physical and Colloid Chemistry

Volodimir Kabachny, National Pharmaceutical University Pushkinska str., 53, Kharkiv, Ukraine, 61002

Doctor of Pharmaceutical Sciences, Professor, Head of Department

Department of Physical and Colloid Chemistry

References

  1. Mashkovskiy, M. D. (2012). Lekarstvennyye sredstva. Мoscow: Novaya Volna, 1216.
  2. Drogovoz, S. M., Rossokhin, V. V. (2008). Prostatoprotektornaya effektivnost' a1-adrenoblokatorov. Provizor, 11, 23–29.
  3. Akinsanya, A., Marwaha, R., Tampi, R. R. (2017). Prazosin in Children and Adolescents With Posttraumatic Stress Disorder Who Have Nightmares. Journal of Clinical Psychopharmacology, 37 (1), 84–88. doi: 10.1097/jcp.0000000000000638
  4. Raskind, M. A., Millard, S. P., Petrie, E. C., Peterson, K., Williams, T., Hoff, D. J. et. al. (2016). Higher Pretreatment Blood Pressure Is Associated With Greater Posttraumatic Stress Disorder Symptom Reduction in Soldiers Treated With Prazosin. Biological Psychiatry, 80 (10), 736–742. doi: 10.1016/j.biopsych.2016.03.2108
  5. Simpson, T. L., Malte, C. A., Dietel, B., Tell, D., Pocock, I., Lyons, R. et. al. (2015). A Pilot Trial of Prazosin, an Alpha-1 Adrenergic Antagonist, for Comorbid Alcohol Dependence and Posttraumatic Stress Disorder. Alcoholism: Clinical and Experimental Research, 39 (5), 808–817. doi: 10.1111/acer.12703
  6. Rasmussen, D. D., Kincaid, C. L., Froehlich, J. C. (2016). Prazosin Prevents Increased Anxiety Behavior That Occurs in Response to Stress During Alcohol Deprivations. Alcohol and Alcoholism, 52 (1), 5–11. doi: 10.1093/alcalc/agw082
  7. Breen, A., Blankley, K., Fine, J. (2016). The efficacy of prazosin for the treatment of posttraumatic stress disorder nightmares in U.S. military veterans. Journal of the American Association of Nurse Practitioners, 29 (2), 65–69. doi: 10.1002/2327-6924.12432
  8. George, K. C., Kebejian, L., Ruth, L. J., Miller, C. W. T., Himelhoch, S. (2016). Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder. Journal of Trauma & Dissociation, 17 (4), 494–510. doi: 10.1080/15299732.2016.1141150
  9. Assad Kahn, S., Costa, S. L., Gholamin, S., Nitta, R. T., Dubois, L. G., Feve, M. et. al. (2016). The anti‐hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ‐dependent inhibition of the AKT pathway. EMBO Molecular Medicine, 8 (5), 511–526. doi: 10.15252/emmm.201505421
  10. Ahmed, J., Al-Haroon, S., Zubairi, M. (2014). Effect of adrenergic blockers, carvedilol, prazosin, metoprolol and combination of prazosin and metoprolol on paracetamol-induced hepatotoxicity in rabbits. Indian Journal of Pharmacology, 46 (6), 644–648. doi: 10.4103/0253-7613.144937
  11. Omar, M. A., Hammad, M. A., Salman, B. I., Derayea, S. M. (2016). Highly sensitive spectrofluorimetric method for determination of doxazosin through derivatization with fluorescamine; Application to content uniformity testing. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 157 (3), 55–60. doi: 10.1016/j.saa.2015.12.012
  12. Gao, N., Wu, H., Chang, Y., Guo, X., Zhang, L., Du, L., Fu, Y. (2015). Mixed micelle cloud point-magnetic dispersive μ-solid phase extraction of doxazosin and alfuzosin. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 134 (1), 10–16. doi: 10.1016/j.saa.2014.06.095
  13. Al-Qaim, F. F., Abdullah, M. P., Othman, M. R., Latip, J., Zakaria, Z. (2014). Multi-residue analytical methodology-based liquid chromatography-time-of-flight-mass spectrometry for the analysis of pharmaceutical residues in surface water and effluents from sewage treatment plants and hospitals. Journal of Chromatography A, 1345 (6), 139–153. doi: 10.1016/j.chroma.2014.04.025
  14. Lip, G. Y., Ferner, R. E. (1995). Poisoning with anti-hypertensive drugs: alpha-adrenoceptor antagonists. Journal of Human Hypertension, 9 (7), 523–526.
  15. Clarke, E. J. C. (2011). Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids and Postmortem Material. London: The Pharm. Press., 2463.
  16. Bakshi, M., Ojha, T., Singh, S. (2004). Validated specific HPLC methods for determination of prazosin, terazosin and doxazosin in the presence of degradation products formed under ICH-recommended stress conditions. Journal of Pharmaceutical and Biomedical Analysis, 34 (1), 19–26. doi: 10.1016/j.japna.2003.08.009
  17. Lakshmi Narasimham, Y. S., Barhate, V. D. (2010). Development and validation of stability indicating UPLC method for the simultaneous determination of beta-blockers and diuretic drugs in pharmaceutical dosage forms. Journal of Chemical Metrology, 4 (1), 1–20.
  18. Shrivastava, A. (2015). Brief review on analysis of Prazosin Hydrochloride. International Journal of Advances in Pharmaceutical Analysis, 5 (4), 69–75.
  19. Baram, G. I. (2005). Khromatograf “Milikhrom A–02“. Opredeleniye veshchestv s primeneniyem baz dannykh «VEZHKH–UF». Novosibirsk: ZAO Institute of Chromatography, 64.
  20. Kovalska, O. V., Bezugliy, P. O., Mamina, О. О. (2010). Khromatohrafichne doslidzhennya pokhidnykh khinazolinu. Ukrayinskyi medychnyi almanakh, 13 (4), 96–97.

Downloads

Published

2017-08-31

How to Cite

Mamina О., & Kabachny, V. (2017). The use of HPLC method for analysis of prazosin hydrochloride suitable for a chemical-toxicological investigation. ScienceRise: Pharmaceutical Science, (4 (8), 41–46. https://doi.org/10.15587/2519-4852.2017.109053

Issue

No. 4 (8) (2017)

Section

Pharmaceutical Science

License

Copyright (c) 2017 Оlena Mamina, Volodimir Kabachny

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons Attribution 4.0 International License copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.

3. Authors have the right to store the final accepted version of the article in an institutional, thematic, or any other repository to ensure visibility and accessibility.